2014, Networking and Pharmacology

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2014

Networking

Pharmacology

Early diagnosis in Alzheimer’s disease: A first step towards better care

Clarivate

SEPTEMBER 11, 2024

Approximately 43% of people with MCI develop dementia due to Alzheimer’s disease within 5 years (Roberts, 2014) (Figure 1). Personalized care relies on pharmacological and non-pharmacological interventions aimed at (temporarily) relieving cognitive and non-cognitive symptoms (Alzheimer’s Association, n.d.; Emblad, S.

Food and Drug Administration

Food and Drug Administration Pharmacology Food FDA

Cala® Launches The Cala kIQ™ System, Offering Meaningful Tremor Relief for Patients With Essential Tremor and Now Parkinson’s Disease

Legacy MEDSearch

JUNE 15, 2023

The Cala kIQ System with TAPS therapy offers a non-invasive, non-pharmacologic solution with minimal side effects. Founded in 2014, the company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. New therapies are under development in neurology, cardiology, and psychiatry.

Patients

Patients Recruitment Pharmacology Management

Webinars

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

MORE WEBINARS

Pharma Rep Focus

Early diagnosis in Alzheimer’s disease: A first step towards better care

Cala® Launches The Cala kIQ™ System, Offering Meaningful Tremor Relief for Patients With Essential Tremor and Now Parkinson’s Disease

Webinars

Stay Connected